HomeOwner SearchCategory Search
Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the Treatment of Refractory/Recurrent Advanced or Metastatic Urothelial Cancer
Visit USCO
hero image
Text Registration
Copyright Title

Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the Treatment of Refractory/Recurrent Advanced or Metastatic Urothelial Cancer

Status

Published

on 27 Jun 2019
Year of Creation
2019
Copyright Claimant
Med-IQ, Inc
Registration Number
TX0008759981
on 27 Jun 2019

Copyright Summary


The U.S. Copyright record (Registration Number: TX0008759981) dated 27 Jun 2019, pertains to an electronic file (eService) titled "Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the Treatment of Refractory/Recurrent Advanced or Metastatic Urothelial Cancer" created in 2019. The copyright holder is Med-IQ, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Med-IQ, Inc.

Copyright Details


Copyright Claimant
Med-IQ, Inc

Application Details


Registration Number
TX0008759981
Registration Date
6/27/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Med-IQ, Inc
Physical Description
Electronic file (eService)
First Publication Nation
United States
Preexisting Material
References

Corporate Authors


Notes


Rights Note: Susan Dembeck, Med-IQ, Inc., 5523 Research Park Drive, Ste 210, Baltimore, MD, 21128, United States, (443) 836-6980, sdembeck@med-iq.com
Material Matter Claimed Note: text

Statements


Application Title Statement: Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the Treatment of Refractory/Recurrent Advanced or Metastatic Urothelial Cancer
Author Statement: Med-IQ, Inc employer for hire Domicile: United States Citizenship: United States Authorship: text
Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

© 2024 reserved by Trademarkia
Show terms & conditions